Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., a company listed in Hong Kong, has recently announced that it planned to issue no more than 120 million shares on the Sci-Tech Innovation Board (STIB) of Shanghai Stock Exchange (SSE), with par value per share of RMB0.1.
